#clinical trials

Collection of clinical trials news, found 94 news.

Microbiome leader Prof. Borody at China FMT Conference calls for investment in Faecal Transplant Clinical Trials to fight serious diseases

Microbiome leader Prof. Borody at China FMT Conference calls for investment in Faecal Transplant Clinical Trials to fight serious diseases

  • 18th May 2017

A future where faecal transplants in China will cure conditions like autism, IBD, arthritis, Parkinson's disease and ...

Samsung Bioepis enters the European biopharmaceutical market with Benepali®, the first fusion protein biosimilar approved by the European Commission

Samsung Bioepis enters the European biopharmaceutical market with Benepali®, the first fusion protein biosimilar approved by the European Commission

  • 18th January 2016

- Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Benepali® – a ...

ASX-listed Holista and Swiss bakery ingredients specialist Veripan announce breakthrough formulae to produce clean-label white bread with lowest glycemic index (GI)

ASX-listed Holista and Swiss bakery ingredients specialist Veripan announce breakthrough formulae to produce clean-label white bread with lowest glycemic index (GI)

  • 12th January 2016

- Australian-listed Holista CollTech Limited (ASX: HCT) announced today a global scientific breakthrough, validated ...

Samsung Bioepis' RENFLEXIS® Infliximab Biosimilar Receives Regulatory Approval in Korea

Samsung Bioepis' RENFLEXIS® Infliximab Biosimilar Receives Regulatory Approval in Korea

  • 4th December 2015

- Samsung Bioepis Co., Ltd. today announced that Korea’s Ministry of Food and Drug Safety (MFDS) has approved ...

CROMSOURCE Announces Industry Leading Timeline and Budget Guarantee

CROMSOURCE Announces Industry Leading Timeline and Budget Guarantee

  • 28th February 2013

-     CROMSOURCE, an international full service contract research organization (CRO), today ...

Stretta® Therapy for GERD Receives Strongest Recommendation in SAGES New Clinical Guideline

Stretta® Therapy for GERD Receives Strongest Recommendation in SAGES New Clinical Guideline

  • 12th February 2013

Grade Recommendation: Strong (Highest)      GREENWICH, Connecticut, Feb. 11, 2013 ...

S1P1 Program Assets Generated by Epix Pharmaceuticals, Inc. and Amgen Will Be Offered for Sale

S1P1 Program Assets Generated by Epix Pharmaceuticals, Inc. and Amgen Will Be Offered for Sale

  • 7th October 2011

-    Joseph F. Finn, Jr., C.P.A. ("Finn") Assignee for the Benefit of Creditors of Epix Pharmaceuticals, ...

Investigational Oral Multiple Sclerosis Therapy Teriflunomide (*) Aubagio (R)) Significantly Reduced

Investigational Oral Multiple Sclerosis Therapy Teriflunomide (*) Aubagio (R)) Significantly Reduced

  • 6th October 2011

-            - Findings from Two-Year Pivotal Phase III TEMSO Trial ...

Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metast

Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metast

  • 26th September 2011

-      March 2011 Data Confirm Strong Treatment Effect of ...

Syneron's elure Advanced Skin Lightening(TM) Products Wins 'BEST OF BEAUTY' in Allure Magazine

Syneron's elure Advanced Skin Lightening(TM) Products Wins 'BEST OF BEAUTY' in Allure Magazine

  • 21st September 2011

-            - elure Advanced Skin Lightening Products captures the ...

Polyplus-transfection Announces the Appointment of ten Additional Biologists and Chemists

Polyplus-transfection Announces the Appointment of ten Additional Biologists and Chemists

  • 16th September 2011

-       - Polyplus-transfection celebrates 10 years of commercial growth and research and ...

World Alzheimer Report 2011 Shows Early Diagnosis of Alzheimer's Disease Has Health, Financial and S

World Alzheimer Report 2011 Shows Early Diagnosis of Alzheimer's Disease Has Health, Financial and S

  • 13th September 2011

-                  Call for Nations to ...

Edison Pharmaceuticals to Provide Expanded Access to EPI-743 for Mitochondrial Disease

Edison Pharmaceuticals to Provide Expanded Access to EPI-743 for Mitochondrial Disease

  • 8th June 2011

-FDA allows use of investigational new drug for life-threatening indications     Edison ...

UGM to hold seminar on nutraseutical products

UGM to hold seminar on nutraseutical products

  • 8th June 2011

Gadjah Mada University (UGM) will hold a national seminar on the benefits, safety and development prospects of ...

Phase III Results Show Mirabegron Improves Key OAB Symptoms

Phase III Results Show Mirabegron Improves Key OAB Symptoms

  • 21st March 2011

-        - First Presentations of European-Australian and North American Phase III Trials ...